Want to see IN:PGHH full AI Analyst Report?
Procter & Gamble Hygiene & Health Care Ltd. (PGHH) Ratios
Procter & Gamble Hygiene & Health Care Ltd. Ratios
IN:PGHH's free cash flow for Q1 2026 was $5.17B. For the 2026 fiscal year, IN:PGHH's free cash flow was decreased by $-420.00M and operating cash flow was $5.59B. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.22 | 1.23 | 1.22 | 1.38 | 1.32 |
| Quick Ratio | 0.99 | 0.98 | 0.99 | 1.18 | 1.05 |
| Cash Ratio | 0.61 | 0.53 | 0.58 | 0.89 | 0.73 |
| Solvency Ratio | 0.85 | 0.88 | 0.68 | 0.62 | 0.67 |
| Operating Cash Flow Ratio | 0.99 | 0.69 | 0.48 | 0.76 | 0.67 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 181.36 |
| Net Current Asset Value | $ 939.00M | $ 890.80M | $ 1.16B | $ 3.04B | $ 1.90B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.39 | 2.38 | 2.40 | 2.26 | 2.28 |
| Debt Service Coverage Ratio | 93.90 | 3793.50 | 28.32 | 64.73 | 43.81 |
| Interest Coverage Ratio | 119.96 | 4661.78 | 67.27 | 71.66 | 70.53 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 3.18 | 0.79 | 9.20 | 4.75 | 5.02 |
| Net Debt to EBITDA | -0.47 | -0.39 | -0.56 | -1.07 | -0.74 |
| Profitability Margins | |||||
| Gross Profit Margin | 57.75% | 56.64% | 61.26% | 57.42% | 44.02% |
| EBIT Margin | 27.47% | 25.97% | 22.97% | 21.50% | 20.23% |
| EBITDA Margin | 27.97% | 26.92% | 24.31% | 22.99% | 21.61% |
| Operating Profit Margin | 26.48% | 24.87% | 42.83% | 20.88% | 20.23% |
| Pretax Profit Margin | 27.25% | 25.55% | 22.33% | 21.50% | 20.26% |
| Net Profit Margin | 20.00% | 18.87% | 16.05% | 17.37% | 14.76% |
| Continuous Operations Profit Margin | 20.00% | 18.87% | 16.05% | 17.37% | 14.76% |
| Net Income Per EBT | 73.42% | 73.84% | 71.87% | 80.78% | 72.87% |
| EBT Per EBIT | 102.91% | 102.75% | 52.14% | 102.94% | 100.12% |
| Return on Assets (ROA) | 47.49% | 48.37% | 36.32% | 31.73% | 34.25% |
| Return on Equity (ROE) | 113.67% | 115.17% | 87.12% | 71.68% | 78.06% |
| Return on Capital Employed (ROCE) | 130.55% | 131.06% | 205.20% | 77.49% | 95.85% |
| Return on Invested Capital (ROIC) | 95.75% | 96.51% | 146.97% | 62.41% | 69.31% |
| Return on Tangible Assets | 47.49% | 48.37% | 36.32% | 37.33% | 39.97% |
| Earnings Yield | 2.71% | 1.92% | 1.25% | 1.57% | 1.23% |
| Efficiency Ratios | |||||
| Receivables Turnover | 17.27 | 14.57 | 12.60 | 15.51 | 17.89 |
| Payables Turnover | 2.09 | 2.41 | 1.91 | 1.71 | 2.80 |
| Inventory Turnover | 8.09 | 8.81 | 7.22 | 7.57 | 9.33 |
| Fixed Asset Turnover | 23.23 | 26.15 | 25.20 | 20.26 | 18.79 |
| Asset Turnover | 2.37 | 2.56 | 2.26 | 1.83 | 2.32 |
| Working Capital Turnover Ratio | 20.66 | 21.18 | 13.36 | 11.38 | 13.99 |
| Cash Conversion Cycle | -108.63 | -84.97 | -111.29 | -141.35 | -70.81 |
| Days of Sales Outstanding | 21.13 | 25.05 | 28.98 | 23.54 | 20.40 |
| Days of Inventory Outstanding | 45.12 | 41.42 | 50.53 | 48.24 | 39.11 |
| Days of Payables Outstanding | 174.89 | 151.45 | 190.80 | 213.13 | 130.33 |
| Operating Cycle | 66.25 | 66.47 | 79.51 | 71.78 | 59.52 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 284.68 | 190.25 | 144.95 | 254.39 | 176.55 |
| Free Cash Flow Per Share | 269.42 | 173.29 | 131.19 | 240.70 | 161.21 |
| Dividend Paid and CapEx Coverage Ratio | 1.03 | 0.86 | 0.52 | 1.60 | 0.93 |
| Capital Expenditure Coverage Ratio | 18.65 | 11.22 | 10.53 | 18.58 | 11.51 |
| Operating Cash Flow Coverage Ratio | 1062.16 | 266.19 | 152.77 | 204.91 | 112.37 |
| Operating Cash Flow to Sales Ratio | 0.22 | 0.14 | 0.11 | 0.21 | 0.15 |
| Free Cash Flow Yield | 2.76% | 1.28% | 0.79% | 1.80% | 1.12% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 36.94 | 51.96 | 79.81 | 63.85 | 81.28 |
| Price-to-Sales (P/S) Ratio | 7.39 | 9.80 | 12.81 | 11.09 | 12.00 |
| Price-to-Book (P/B) Ratio | 42.00 | 59.85 | 69.53 | 45.77 | 63.44 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 36.18 | 78.41 | 126.51 | 55.42 | 89.42 |
| Price-to-Operating Cash Flow Ratio | 34.24 | 71.42 | 114.49 | 52.44 | 81.65 |
| Price-to-Earnings Growth (PEG) Ratio | 40.59 | 2.02 | -173.68 | 3.59 | -6.97 |
| Enterprise Value Multiple | 25.95 | 36.02 | 52.13 | 47.15 | 54.77 |
| Enterprise Value | 310.75B | 436.28B | 533.03B | 423.42B | 461.74B |
| EV to EBITDA | 25.95 | 36.02 | 52.13 | 47.15 | 54.77 |
| EV to Sales | 7.26 | 9.70 | 12.67 | 10.84 | 11.84 |
| EV to Free Cash Flow | 35.53 | 77.56 | 125.17 | 54.19 | 88.24 |
| EV to Operating Cash Flow | 33.63 | 70.65 | 113.28 | 51.28 | 80.57 |
| Tangible Book Value Per Share | 232.12 | 227.04 | 238.71 | 213.86 | 160.04 |
| Shareholders’ Equity Per Share | 232.12 | 227.04 | 238.71 | 291.44 | 227.22 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.27 | 0.26 | 0.28 | 0.19 | 0.27 |
| Revenue Per Share | 1319.04 | 1386.04 | 1295.63 | 1203.06 | 1201.73 |
| Net Income Per Share | 263.86 | 261.48 | 207.95 | 208.91 | 177.37 |
| Tax Burden | 0.73 | 0.74 | 0.72 | 0.81 | 0.73 |
| Interest Burden | 0.99 | 0.98 | 0.97 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.12 | 0.19 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.79 | 0.73 | 0.70 | 0.98 | 0.73 |
Currency in INR
